Browse Category

Solutions

New Medical Solutions curates credible advances that solve real problems in healthcare—faster diagnosis, safer procedures, better monitoring, smoother coordination, and fairer access.

Amid industry’s cell therapy automation push, Cellares and Ori dominate the field: report

With interest in automated cell therapy production beginning to build from about 2016 onward, some 23 companies working in the field have now raised a collective $1.1 billion across 34 rounds through

June 18, 2026

News·Solutions

Novo Nordisk opens Czech plant and unveils $29M upgrade to China facility

Eighteen months after Novo Nordisk purchased a plant in the Czech Republic from Novavax, the Danish drugmaker said it is set to kick off the manufacturing of ingredients for next-generation diabetes and

June 17, 2026

News·Solutions

Recipharm channels ‘multi-million-dollar’ US manufacturing upgrade, targeting domestic biologics demand

Recipharm has sketched out a “multi-million-dollar” investment in its U.S. manufacturing operations as part of a move to boost its sterile fill-finish capabilities and other production offerings for customers.

June 16, 2026

News·Solutions

Eisai snares government manufacturing grant as it brings Leqembi packaging to UK with $65M expansion

As the United Kingdom juggles industry concerns about the region’s waning appeal and competitiveness, Eisai is getting a lift from a production-tinged fund that the British government first unveiled in 2024.

June 15, 2026

News·Solutions

Teva to lay off 250 at API unit as search for new owner drags on: report

Teva plans to remove 250 jobs at its CDMO unit over the next two years, Israeli business news outlet Globes reports.

June 10, 2026

News·Solutions

Hikma earmarks $267M to expand pair of Ohio production sites, add 350 jobs

Hikma Pharmaceuticals plans to spend $267 million to expand a pair of manufacturing facilities in Ohio as part of the $1 billion the U.K. drugmaker committed a year ago to build out

June 8, 2026

News·Solutions

Medline earns FDA warning letter ire for repeated toxic bacteria problems

Medical device distribution giant Medline has been slammed for a second time since April by an FDA warning letter that has chided the company for repeated problems centered on the presence of

June 4, 2026

News·Solutions

ADHD drug delivery specialist Cingulate hit with manufacturing-related FDA rejection

Cingulate will need to take a detour to win its first FDA approval, as the agency has rejected its lead candidate over manufacturing concerns.

June 2, 2026

News·Solutions

MedTech In Focus: AI impact in healthcare

We are seeing it everywhere, Artificial Intelligence in our daily activities – smart thermostats and smart lights in our homes, facial recognition on our phones, robot vacuum cleaners doing our cleaning, navigation

June 1, 2026

Solutions

Viridian, awaiting FDA decision, taps WuXi Bio in eye drug supply deal

Viridian aims to challenge Amgen in a blockbuster market, and it’s now tapped Chinese CDMO giant WuXi Biologics in a manufacturing pact.

May 27, 2026

News·Solutions

1 2 3 … 20 Next

Go toTop